US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $20 ...

Findings presented at NSGC 2026 show 62% of patients with pathogenic or likely pathogenic findings had results associated ...

Luminoah, a medical technology company modernizing enteral nutrition, today announced a $25 million Series B financing led by ...

The acquisition brings differentiated bioconjugation technology and expertise to complement AstraZeneca’s capabilities in ...

The gross proceeds to the Company from this offering are expected to be approximately $30 million, before deducting ...

For a small biotech or technology company, getting started can mean more than having a good idea. There is the lab space, the ...

BioBuzz’s Buzzin’ Brood Student Spotlight series celebrates the future of life sciences talent — and the programs, ...

Ask most college students what a career in life sciences looks like, and they’ll picture a lab coat, a microscope and a bench ...

AbelZeta Inc. (“AbelZeta” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery ...

All of the shares of common stock, Pre-Funded Warrants and the accompanying warrants are being offered by Annovis. The shares ...

Regenerative medicine company Theradaptive celebrated the opening of its $15 million manufacturing expansion with a ...

Collaboration pairs tissue and blood samples from disease-specific populations with patient outcomes data to power Network ...